Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
START analysis looks at who benefits most from immediate HIV treatment

Starting antiretroviral therapy (ART) soon after HIV diagnosis led to better outcomes than delayed treatment in all population sub-groups in the START trial, researchers reported at the

Published
04 August 2016
By
Liz Highleyman
Searching for the next ‘Berlin patient’: doctors document bone-marrow recipients with HIV

The ‘Berlin patient’, Timothy Ray Brown, has now survived seven years off antiretroviral therapy with no sign of HIV reappearing in his body, and as time passes

Published
01 August 2016
By
Gus Cairns
Think the Aids epidemic is over? Far from it – it could be getting worse

The 2000 Aids conference in Durban shocked the world into action. Now, a new crisis looms, one fuelled by drug resistance, costly treatments and the lack of power many women have in sexual relationships.

Published
31 July 2016
From
The Guardian
Hope for 'end of Aids' is disappearing, experts warn

Those fighting epidemic say 2030 target is unrealistic as efforts to defeat it falter amid rising infection levels and drug resistance.

Published
31 July 2016
From
The Guardian
Reducing clinic visits can support retention in HIV care, African studies show

Interventions which reduce the need for people to attend clinics are proving highly successful in retaining people in care and supporting adherence to HIV medication in southern

Published
26 July 2016
By
Keith Alcorn
Early HIV treatment: mothers say they need time to think

Findings from the first randomised controlled trial to date evaluating postpartum antiretroviral therapy (ART) for women with high CD4 cell counts (over 400 cells/mm3) highlight a critical need

Published
26 July 2016
By
Carole Leach-Lemens
Women with HIV have higher risk of loss to follow-up and death after delivery

Despite the widespread implementation of Option B+ (lifelong antiretroviral therapy (ART) for pregnant and breastfeeding women regardless of CD4 cell count) postpartum HIV-positive women remain at higher risk

Published
26 July 2016
By
Carole Leach-Lemens
Once-daily raltegravir works as well as twice-daily for initial HIV treatment

A new formulation of the integrase inhibitor raltegravir (Isentress) taken once daily suppressed HIV viral load as well as the older formulation taken twice a day in people

Published
26 July 2016
By
Liz Highleyman
Dolutegravir plus lamivudine dual therapy works well as initial HIV treatment

A two-drug regimen of dolutegravir and the well-tolerated NRTI lamivudine led to sustained viral suppression for most people starting antiretroviral therapy (ART) for the first time in a

Published
25 July 2016
By
Liz Highleyman
Earlier HIV treatment is not over-burdening health services

Earlier treatment initiation is not overwhelming rural health services in South Africa, but changes in treatment eligibility criteria alone may not increase the number of people on

Published
22 July 2016
By
Keith Alcorn

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close